A Study to Investigate the Efficacy and Safety of Roxadustat (FG-4592) for Treating Anemia in Participants With Myelodysplastic Syndromes (MDS)
Clinical trial NCT07722988 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07722988
- Sponsor
- Kyntra Bio
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2027-04-01
- Primary completion
- 2030-09-01
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.